S&P 500 Healthcare Sector SEC Filings — April 29, 2026

29-04-2026

Humana reported Q1 2026 GAAP EPS of $9.83, down 4.6% YoY from $10.30, and Adjusted EPS of $10.31, down 10.9% from $11.58, with consolidated pretax income of $1,595 million versus $1,691 million YoY. Insurance segment benefit ratio was 89.4%, favorable to guidance of just under 90%, while affirming FY 2026 benefit ratio guidance of 92.75% +/- 25 basis points and individual Medicare Advantage membership growth of approximately 25% over 2025; however, GAAP EPS guidance was revised down to at least $8.36 from at least $8.89 due to Star Ratings headwind, with Adjusted EPS affirmed at least $9.00 anticipating YoY decline. CenterWell Senior Primary Care grew sequentially by over 22% with 110,500 new patients, including from MaxHealth acquisition, and state-based contracts added approximately 50,000 members.

• ·George Renaudin retiring effective June 29, 2026; Aaron Martin assumes Insurance Segment President role then, currently leading day-to-day; John Barger leading Medicare Advantage operations immediately.
• ·Operating cost ratio Adjusted improved to 10.0% in 1Q26 from 10.5% in 1Q25.
• ·FY 2025 reported Adjusted EPS $17.14.

29-04-2026

Woori Financial Group Inc. (WFG) executed a Share Exchange Agreement with TONGYANG Life Insurance Co., Ltd. on April 29, 2026, to acquire the remaining 24.66% of Tongyang's shares it does not already own (currently holding 75.34% or 121,565,627 shares), making Tongyang a wholly-owned subsidiary aimed at enhancing management efficiency and reducing costs. Under the agreement, minority Tongyang shareholders will receive 0.2521056 WFG new shares per Tongyang share, with WFG issuing 8,696,875 new shares and increasing its capital stock by KRW 43,484,375,000. The share exchange is scheduled for August 11, 2026, following board approvals on July 24, 2026, subject to regulatory approvals and no material adverse effects.

• ·Share exchange ratio: 0.2521056 WFG shares per Tongyang share
• ·Board of directors meetings for approval: July 24, 2026 (WFG small-scale; Tongyang general meeting)
• ·Share Exchange Date: 00:00 hours on August 11, 2026 (subject to adjustment)
• ·Conditions precedent include regulatory approvals, no prohibiting orders, and no material adverse effects
• ·Fractional shares paid in cash based on WFG closing price on listing date

29-04-2026

First Financial Bankshares, Inc. held its 2026 annual shareholder meeting on April 28, 2026, electing 13 directors with strong support (votes for ranging from 104,350,901 to 110,039,940, withheld votes under 6.2 million each) amid 18,114,378 broker non-votes. Shareholders ratified Ernst & Young LLP as independent auditors for the year ending December 31, 2026, with 126,353,649 votes for, 2,020,446 against, and 225,999 abstentions. An advisory vote approving named executive officer compensation passed with 101,942,536 for, 4,885,300 against, and 3,657,880 abstentions, also with 18,114,378 broker non-votes.

• ·Director votes for/withheld: Vianei Lopez Braun (108,412,469/2,073,247), David L. Copeland (107,215,734/3,269,982), Sally Pope Davis (109,796,816/688,900), Michael B. Denny (109,801,149/684,567), F. Scott Dueser (109,029,741/1,455,975), Murray H. Edwards (106,861,853/3,623,863), Geoff Haney (110,012,056/473,660), Eli Jones Ph.D. (109,434,868/1,050,848), I. Tim Lancaster (104,350,901/6,134,815), Kade L. Matthews (108,566,159/1,919,557), Robert C. Nickles (108,239,063/2,246,653), Blake Poutra (110,039,940/445,776), Lota S. Zoth (109,994,472/491,244)

29-04-2026

Central Pacific Financial Corp. reported Q1 2026 net income of $20.7 million ($0.78 diluted EPS), down 9.6% QoQ from $22.9 million ($0.85 EPS) but up 16.3% YoY from $17.8 million ($0.65 EPS). Balance sheet grew modestly with total assets at $7.50 billion (up 1.2% QoQ), loans at $5.32 billion (up 0.6% QoQ but down 0.3% YoY), and deposits at $6.70 billion (up 1.4% QoQ and 1.6% YoY), while net interest income declined 1.2% QoQ to $61.4 million despite a stable NIM of 3.53% (down 3 bps QoQ). The company repurchased 321,396 shares for $10.5 million and approved a Q2 dividend of $0.29 per share, and Central Pacific Bank was named SBA Lender of the Year in Hawaii.

• ·Provision for credit losses $2.4 million Q1 2026, flat QoQ but down from $4.2 million YoY
• ·Nonperforming assets $14.5 million or 0.19% of total assets at March 31 2026, up slightly QoQ and YoY
• ·Net charge-offs $2.4 million or 0.18% annualized of average loans Q1 2026, flat QoQ
• ·Allowance for credit losses on loans 1.13% of total loans at March 31 2026, unchanged QoQ and YoY
• ·Regulatory capital: leverage ratio 9.7%, CET1 12.6%, Tier 1 13.5%, total risk-based 14.7% at March 31 2026
• ·Q2 dividend $0.29 per share payable June 15, 2026 to shareholders of record May 29, 2026

29-04-2026

Biogen reported first quarter 2026 total revenue of $2.5 billion, up 2% YoY, driven by 12% growth in growth products including LEQEMBI (+74% to $168 million) and SKYCLARYS (+22% to $151 million), though SPINRAZA declined 12% YoY to $374 million and multiple sclerosis revenue remained flat. Non-GAAP diluted EPS rose 18% to $3.57. The company announced a proposed acquisition of Apellis Pharmaceuticals, expected to be accretive in 2027, and updated full-year 2026 guidance to Non-GAAP diluted EPS of $14.25-$15.25 amid expected mid-single digit total revenue decline.

• ·Litifilimab Phase 2 showed meaningful reduction in disease activity at Week 16 for CLE patients.
• ·Salanersen Phase 1b data showed new motor milestones in SMA children post gene therapy.
• ·LEQEMBI real-world persistence: 78% at 18 months.
• ·SPINRAZA High Dose Regimen approved by FDA, Japan, EU.
• ·Full year 2026 total revenue expected to decline mid-single digit percentage vs 2025.
• ·Acquired IPR&D charges: ~$1.00 impact on FY2026 Non-GAAP EPS ($0.20 in Q1, $0.80 in Q2).

29-04-2026

News Corporation filed an 8-K disclosing information provided to the Australian Securities Exchange (ASX) regarding its ongoing $1 billion stock repurchase program for Class A (NWSA) and Class B (NWS) common stock, with details attached as Exhibits 99.1 and 99.2. The program authorizes repurchases from time to time, subject to market conditions and regulations. No specific repurchase transactions or amounts were detailed in the filing body.

• ·Event date: April 28, 2026
• ·Filing date: April 29, 2026
• ·Securities registered: Class A Common Stock (NWSA), Class B Common Stock (NWS)

29-04-2026

Apollo Commercial Real Estate Finance, Inc. (ARI) reported first quarter 2026 results with net income available to common stockholders of $0.16 per diluted share and Distributable Earnings of $0.22 per diluted share. No realized losses were recorded during the quarter. A detailed presentation is available at www.apollocref.com, with a conference call scheduled for April 29, 2026 at 10am ET.

• ·Conference call registration link: https://register-conf.media-server.com/register/BI073b00720c8d4549af7fd43ddcdbcb97
• ·Distributable Earnings defined as net income adjusted for equity-based compensation, unrealized gains/losses, unrealized JV income, certain foreign currency gains/losses, and CECL provision
• ·No realized losses recorded in the consolidated statement of operations for the three months ended March 31, 2026

29-04-2026

Phoenix New Media Limited reported consolidated third-party revenues of RMB 765,571 thousand for the year ended December 31, 2025, up 8.8% YoY from RMB 703,695 thousand, driven by growth in VIEs and subsidiaries, while gross profit surged 39.3% to RMB 374,149 thousand. However, total operating expenses increased 22.5% to RMB 408,526 thousand, leading to an operating loss of RMB 34,377 thousand (improved from RMB 64,721 thousand prior year), and total assets declined 3.6% to RMB 1,649,789 thousand with cash down 11.5% to RMB 537,549 thousand. Net income attributable to the company turned positive at RMB 336 thousand from a RMB 53,554 thousand loss in 2024.

• ·Workforce totals 611 employees across functions including 192 in content development and 178 in sales and marketing.
• ·Consolidated revenues for 2023 were RMB 692,020 thousand.
• ·Shareholders' equity attributable to Phoenix New Media Limited was RMB 1,171,143 thousand as of Dec 31, 2025.

29-04-2026

Regeneron reported first quarter 2026 total revenues of $3,605 million, up 19% YoY from $3,029 million, driven by 36% growth in Sanofi collaboration revenue to $1,605 million (including Dupixent global net sales up 33% to $4.9 billion) and EYLEA HD U.S. net sales up 52% to $468 million. However, total U.S. EYLEA HD and EYLEA net sales declined 10% YoY to $941 million due to a 36% drop in EYLEA U.S. sales to $473 million, GAAP net income fell 10% to $727 million, and GAAP EPS decreased 7% to $6.75. Non-GAAP EPS increased 15% to $9.47, supported by multiple new product approvals and a new $3.0 billion share repurchase authorization.

• ·EYLEA HD approved by FDA for dosing intervals up to 5 months in wAMD and DME.
• ·Dupixent approved by FDA and EC for CSU in children aged 2-11; FDA approval for AFRS.
• ·Otarmeni approved by FDA as first gene therapy for genetic hearing loss; provided free in U.S.
• ·GAAP gross margin on net product sales lowered to 77%-78% for FY2026 due to manufacturing interruption in Ireland.
• ·New $0.94 per share cash dividend declared, payable June 4, 2026.
• ·Samsung EYLEA biosimilar launch precluded until January 2027 per settlement.

29-04-2026

Tradeweb Markets Inc. reported Q1 2026 revenues of $617.8 million, up 21.2% YoY (17.5% constant currency), with Rates revenues surging 29.7% to $344.2 million and total ADV hitting a record $3.3 trillion, up 31.4% YoY, alongside international revenues of $274.1 million rising 29.4%. Net income grew 38.5% to $233.2 million, adjusted EBITDA reached $339.7 million with a 55.0% margin (up from 54.6%), and adjusted diluted EPS was $1.08. However, Market Data revenues fell 4.6% to $36.9 million due to changes in the LSEG agreement timing, cash credit average variable fees per million declined 14.7%, and certain U.S. credit TRACE market shares decreased (e.g., fully electronic high grade down 33 bps YoY).

• ·Credit derivatives ADV up 59.5% YoY; U.S. credit ADV up 14.0% YoY with records in fully electronic high grade and high yield; European credit ADV up 21.2% YoY.
• ·17.7% share of fully electronic U.S. high grade TRACE (down 33 bps YoY); 25.0% total share of U.S. high grade TRACE (down 92 bps YoY).
• ·Municipal bond ADV up 5.0% YoY, outperforming market (down 1%).
• ·Equities ADV up 22.6% YoY with records in U.S. and international ETFs.
• ·Money Markets ADV up 13.2% YoY with records in global repurchase agreements.
• ·Declared $0.14 per share quarterly cash dividend, up 16.7% YoY.
• ·Strategic partnership and minority investment in Kalshi; led $31M Series B in Crossover Markets for institutional spot crypto liquidity.

29-04-2026

Fannie Mae earned $3.7 billion in net income for Q1 2026, up 5% QoQ from $3.5 billion in Q4 2025, driven by steady $7.3 billion net revenues from a stable $4.1 trillion guaranty book and a 19% reduction in administrative expenses; net worth rose 3% to $112.7 billion. Single-family net income grew 19% to $3.2 billion with acquisition volume up slightly to $98.7 billion, while illustrative return on average required CET1 capital improved to 10.4% from 10.2%. However, multifamily net income fell 36% to $546 million due to higher credit loss provisions of $174 million (vs $5 million QoQ) and acquisition volume down to $17.1 billion from $25.8 billion, with delinquency rate rising to 0.78%.

• ·Single-family serious delinquency rate unchanged at 0.58% as of Mar. 31, 2026.
• ·Multifamily serious delinquency rate increased to 0.78% as of Mar. 31, 2026 from 0.74%.
• ·More than 80% of multifamily units financed were affordable to renters earning less than 100% of area median income.
• ·First-time homebuyers accounted for more than half of single-family purchase mortgages.
• ·Single-family weighted-average FICO at origination: 753; mark-to-market LTV: 51%.
• ·Multifamily weighted-average original LTV: 63%; debt service coverage ratio: 1.9x.

29-04-2026

Coastal Financial Corporation (Nasdaq: CCB) reported Q1 2026 net income of $12.0 million ($0.78 diluted EPS), down from $12.6 million ($0.82) in Q4 2025 but up from $9.7 million ($0.63) in Q1 2025, amid strong balance sheet growth with total assets up 19.5% QoQ to $5.66 billion and deposits up 21.6% QoQ to $5.04 billion. Loans receivable grew 2.9% QoQ to $3.86 billion, and CCBX BaaS fee income rose 22.3% QoQ to $10.9 million; however, noninterest expenses increased due to higher legal/professional fees and BaaS loan expenses, ROA declined 0.11% QoQ to 0.98%, and provision for credit losses rose to $51.4 million. The company advanced CCBX partner expansions with two in testing, three onboarding, and two LOIs signed.

• ·Nonperforming assets to total assets improved to 1.19% from 1.35% QoQ.
• ·Provision for credit losses $51.4M in Q1 2026 vs $48.0M in Q4 2025.
• ·Noninterest expenses $83.5M in Q1 2026, up from $72.8M in Q4 2025 due to $2.6M higher legal/professional fees.
• ·Full-time equivalent employees decreased to 496 from 517 YoY.
• ·Off-balance sheet credit cards increased 116,046 QoQ to 667,023.

29-04-2026

Virtu Financial reported robust Q1 2026 results, with total revenues surging 30.7% YoY to $1,095.3 million and trading income, net, up 33.8% to $789.1 million. Net income rose sharply to $346.6 million from $189.6 million, Adjusted EBITDA climbed 62.7% to $520.6 million, and the Board declared a quarterly dividend of $0.24 per share. However, Execution Services trading income, net, dipped slightly by 8.6% to $6.7 million YoY, while Corporate segment revenues were negative at $(7.5) million.

• ·Basic and diluted EPS of $1.99 (vs. $1.09 basic and $1.08 diluted YoY); Normalized Adjusted EPS of $2.24 (vs. $1.30 YoY)
• ·Dividend payable June 15, 2026 to shareholders of record June 1, 2026
• ·Earnings conference call on April 29, 2026 at 8:00 a.m. ET

29-04-2026

HBT Financial, Inc. filed an 8-K/A attaching the audited 2025 consolidated financial statements of CNB Bank Shares, Inc., the target of its acquisition, showing total assets of $1,797.5M (up 2.2% from $1,759.2M in 2024) and net income of $16.4M (up 20.3% from $13.7M). Net interest income grew 15.6% to $61.4M, driven by higher loan interest, while deposits increased 3.3% to $1,489.6M; however, noninterest expenses rose 11.1% to $49.9M amid higher salaries and professional fees.

• ·Basic EPS $2.89 in 2025 (up from $2.43 in 2024).
• ·Total comprehensive income $30.8M in 2025 (up from $11.7M in 2024, driven by $14.4M other comprehensive income).
• ·Auditor's report dated February 25, 2026, with unqualified opinion.

29-04-2026

Citizens Financial Services, Inc. reported Q1 2026 net income of $10.4 million and diluted EPS of $2.16, with core ROATCE steady at 16.15% and net interest margin improving slightly to 3.72% from 3.69%. However, total assets declined 1.2% to $3.0 billion, core ROAA decreased to 1.34% from 1.37%, efficiency ratio worsened to 54.98% from 54.03%, and credit quality deteriorated with NPAs/assets rising to 1.33% from 0.95%, NPLs/gross loans to 1.64% from 1.14%, and reserves/NPLs falling to 60.7% from 85.0%. Deposits grew 2.7% to $2.4 billion (0.5% excluding brokered deposits), while loans increased 2.4% to $2.3 billion (0.5% excluding brokered deposit growth).

• ·Company founded in 1872, headquartered in Mansfield, PA, with 43 branches.
• ·Institutional ownership: 29.22%; 3-month ADTV: 8,789 shares.
• ·52-week stock high/low: $69.58 / $49.99.
• ·Historical NCOs/Avg Loans annualized: 0.03% recently.
• ·Total whole bank acquisitions since 2015 added $1,072M in target assets.

29-04-2026

Lakeland Financial Corp reported Q1 2026 net income of $26,478 thousand, up 31.8% YoY from $20,085 thousand, supported by net interest income growth of 7.4% to $56,773 thousand, higher noninterest income of $12,933 thousand (+18.4%), and a sharply lower provision for credit losses of $2,000 thousand (-70.6% YoY). Total assets expanded 1.3% QoQ to $7,083,680 thousand, driven by 3.6% deposit growth to $6,190,260 thousand and 1.8% net loan growth to $5,404,444 thousand. However, stockholders' equity declined 1.8% QoQ to $748,904 thousand amid $19,369 thousand in share repurchases and an $8,485 thousand net other comprehensive loss, resulting in comprehensive income falling 20.7% YoY to $17,993 thousand.

• ·Diluted EPS $1.04 for Q1 2026, up from $0.78 in Q1 2025.
• ·Cash dividends declared and paid at $0.52 per share (Q1 2026) vs $0.50 (Q1 2025).
• ·Treasury shares purchased: 336,853 under repurchase plan (Q1 2026).
• ·Total borrowings decreased to $68,200 thousand from $184,200 thousand QoQ.

29-04-2026

Franklin Financial Services Corporation held its annual meeting of shareholders on April 28, 2026, where all proposals were approved. Shareholders elected four Class A Directors (Craig W. Best, G. Warren Elliott, Stanley J. Kerlin, and Kimberly M. Rzomp) for three-year terms, approved the advisory vote on named executive officers' compensation, and ratified Crowe LLP as the independent registered public accounting firm for 2026. While all directors received majority support, G. Warren Elliott faced notably higher withheld votes (421,297) compared to the others.

29-04-2026

Credit Industriel et Commercial filed its 13F-HR on April 29, 2026, disclosing U.S. securities holdings totaling $1,283,822,105 across 349 positions as of March 31, 2026. The portfolio includes a mix of common stocks, put options, call options, and notes in sectors like healthcare (e.g., Hologic at $15,439,258), technology, and ETFs, with significant put positions such as iShares Russell 2000 ETF ($53,320,000). No period-over-period changes are provided in the filing.

• ·Filing covers period ending 2026-03-31.
• ·Includes positions in affiliated managers: Banque Transatlantique SA, Banque de Luxembourg S.A., BLI - Banque de Luxembourg Investments.

29-04-2026

Citizens Community Bancorp, Inc. (CZWI) filed its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders on June 16, 2026, at 4:00 p.m. local time in Eau Claire, Wisconsin, with a record date of April 10, 2026, and 9,628,612 shares of Common Stock outstanding. Shareholders will vote on electing directors Michael Conner, Francis Felber, and Nicholas Amundsen for three-year terms; approving the 2026 Omnibus Incentive Plan; a non-binding advisory vote on executive compensation; and ratifying Crowe LLP as independent auditors for FY 2026. No financial performance metrics or period-over-period comparisons are detailed in the filing.

• ·Annual Meeting location: Holiday Inn Eau Claire South, 4751 Owen Ayres Ct, Eau Claire, Wisconsin 54701.
• ·Quorum requires stockholders holding a majority of Common Stock entitled to vote, present in person or by proxy.
• ·Directors elected by plurality vote; other proposals require majority of votes cast.
• ·Proxy solicitation primarily by mail, with assistance from Regan & Associates.

29-04-2026

Baxter International Inc. filed definitive additional proxy materials urging shareholders to vote 'FOR' a Proposed Charter Amendment to reduce the minimum number of directors from nine to seven and eliminate the maximum number, with the exact size fixed by the Board. In response to investor feedback, the Board adopted a Bylaws Amendment setting the board size range at seven to twelve members, effective only if the Charter Amendment passes. This framework aims to provide flexibility for board refreshment while maintaining governance guardrails.

• ·Filing date: April 29, 2026
• ·Bylaws Amendment takes effect only if stockholders approve the Proposed Charter Amendment
• ·Supplement to be read with original Proxy Statement; does not otherwise amend it

29-04-2026

Cary Street Partners Financial LLC reported total holdings valued at exactly $4,036,604,971 across 1,357 positions in its 13F-HR filing as of March 31, 2026. Top holdings include Apple Inc. COM with a value of $112,768,048 (444,336 shares), Alphabet Inc. CAP STK CL C with $57,683,412 (201,086 shares), and Amazon.com Inc. COM with $42,552,407 (204,314 shares), reflecting heavy exposure to technology leaders and diversified ETFs. No period-over-period changes are disclosed in this snapshot filing.

• ·Filing submitted on April 29, 2026, for period ending March 31, 2026
• ·Business address: 901 East Byrd Street, Suite 1001, Richmond, VA 23219
• ·SEC file number: 028-23044
• ·Previous names include Luxon Financial LLC and Cary Street Partners Holdings, LLC

29-04-2026

Capitol Federal Financial, Inc. reported Q2 FY2026 net income of $20.1 million, a slight decrease from $20.3 million in the prior quarter primarily due to a higher provision for credit losses of $2.4 million versus $1.1 million. Net interest income increased $949 thousand to $52.3 million with net interest margin expanding 5 basis points to 2.24%, driven by reductions in borrowings and growth in commercial loans ($39.1 million to $2.32 billion) and deposits ($20.4 million to $548.1 million). Total assets reached $9.83 billion, while the company repurchased $22.4 million in shares and paid $15.9 million in dividends, including a special dividend.

• ·Tangible book value per share of $7.96 at March 31, 2026.
• ·Provision for credit losses included $4.0 million specific valuation allowance for a nonaccrual commercial lending relationship.
• ·Announced cash dividend of $0.085 per share payable May 15, 2026.
• ·Bank anticipates moving at least $25.0 million to holding company in Q3 FY2026 for dividends and repurchases.
• ·Commercial loans comprised 29% of total portfolio at March 31, 2026, up from 28% at Dec 31, 2025.

29-04-2026

For the year ended December 31, 2025, Asia Pacific Wire & Cable Corp Ltd (APWC) reported total revenue of $489,679 thousand, up 3.6% YoY from $472,672 thousand in 2024, driven by 18.8% growth in North Asia to $86,293 thousand, while Thailand grew modestly 2.3% to $176,862 thousand but ROW was flat/down 0.3% at $226,524 thousand. However, operating profit declined sharply 36.3% to $6,377 thousand from $10,008 thousand due to a 1.9% drop in gross profit to $34,427 thousand and 10.2% higher SG&A expenses at $28,502 thousand; profit attributable to equity holders rose modestly 5.3% to $3,670 thousand.

• ·North Asia operating profit improved to $304 thousand in 2025 from $(445) thousand loss in 2024.
• ·Corporate expenses & adjustments increased to $(2,396) thousand in 2025 from $(1,878) thousand.
• ·2024 revenue grew 11.0% YoY from 2023's $425,772 thousand.
• ·Non-controlling interests profit declined 49.9% to $1,544 thousand in 2025.

29-04-2026

Miramar Fiduciary Corp filed its 13F-HR on April 29, 2026, disclosing holdings as of March 31, 2026, with a total portfolio value of $121,979,064 across 5 positions held solely. The largest holding is Dimensional ETF Trust Intl Core Equity (1,915,823 shares valued at $68,069,191), followed by Dimensional ETF Trust Emerging Mkts Co ($31,180,788). Other positions include Dimensional ETF Trust Intl Small Cap V ($16,114,316), Scripps E W Co Ohio Cl A New ($3,969,701), and SPDR S&P 500 ETF Tr ($2,645,068); no prior period comparisons or changes are detailed in the filing.

• ·Filing period end date: March 31, 2026
• ·All positions held as SOLE with 0 SH/PUT/CALL

29-04-2026

On April 27, 2026, Tri-State Generation and Transmission Association, Inc. received notice from its Chief Administrative Officer and Chief Human Resources Officer, Elda de la Peña, that she intends to retire in December 2026 after more than 29 years of service. Tri-State plans to initiate a search for a successor. No immediate disruption to operations is indicated.

• ·Tri-State's principal executive offices: 1100 W. 116th Avenue, Westminster, Colorado 80234
• ·Telephone: (303) 452-6111
• ·Filing date: April 29, 2026

29-04-2026

Police & Firemen's Retirement System of New Jersey filed its 13F-HR on April 29, 2026, disclosing equity holdings as of March 31, 2026, with no reported changes in share counts (0 delta shares) across the listed positions. The portfolio features large positions in technology leaders including Amazon.com Inc (307611041 USD market value), Alphabet Inc Class A (257112860 USD), and Alphabet Inc Class C (209332643 USD), alongside healthcare names like AbbVie Inc (59324312 USD). Exposure spans diverse sectors such as technology, healthcare, and telecommunications, with ATT Inc at 30882583 USD.

• ·Filer CIK: 0002040686
• ·SEC File Number: 028-24908
• ·Business address: 50 W State Street, Suite 1100, Trenton, NJ 08625
• ·Phone: 6099842885
• ·Fiscal year end: 0630
• ·No share or value changes reported (0 0 deltas) for listed holdings

29-04-2026

KERR FINANCIAL PLANNING Corp filed its 13F-HR on April 29, 2026, disclosing 528 sole discretionary equity positions totaling $81380576 as of March 31, 2026. The portfolio shows heavy concentration in technology and innovation-themed investments, with top holdings including Apple Inc ($3938340, 14601 shares), Amazon.com Inc ($3133655, 12127 shares), and ARK Innovation ETF ($2623258, 34782 shares). Other notable positions include Advanced Micro Devices Inc ($1584372, 4925 shares) and multiple AI, crypto, and ETF exposures, reflecting a growth-oriented strategy with no reported shared discretion, puts, calls, or other managers.

• ·All positions reported as sole discretionary (SH SOLE) with no put/call, investment discretion, or other manager involvement.
• ·Portfolio address: 7255 N First Street Suite 101, Fresno, CA 93720.
• ·SEC file number: 028-25892.
• ·Significant exposure to ARK ETFs (e.g., Autonomous Technology & Robotics, Genomic Revolution), crypto ETFs (e.g., Grayscale Bitcoin Trust, ProShares Bitcoin ETF), and AI/tech stocks.

29-04-2026

Principal Financial Group, Inc. reported net income attributable to the company of $424.6 million for the three months ended March 31, 2026, a significant increase from $48.1 million in the prior year period, driven by lower benefits and claims expenses ($1,611.1 million vs. $2,220.0 million) and a favorable swing in the change in fair value of funds withheld embedded derivative ($177.4 million gain vs. $209.7 million loss). However, total revenues declined 4.5% YoY to $3,529.1 million, primarily due to a 34.4% drop in premiums and other considerations to $1,148.1 million, while total assets decreased 2.5% to $332,704.5 million from $341,376.5 million at December 31, 2025, and operating cash flow fell sharply to $187.1 million from $977.3 million.

• ·Cash and cash equivalents decreased to $4,054.0 million from $4,431.0 million at December 31, 2025.
• ·Separate account assets declined to $185,788.4 million from $193,622.6 million at December 31, 2025.
• ·Stockholders’ equity attributable to PFG decreased slightly to $11,815.3 million from $11,883.9 million at December 31, 2025.
• ·Net unrealized losses on available-for-sale securities of $578.5 million contributed to other comprehensive loss of $161.0 million in Q1 2026.
• ·Treasury stock acquired: $235.9 million in Q1 2026 vs. $241.3 million in Q1 2025.
• ·Upcoming accounting standards adoption dates: January 1, 2027 (Credit losses on purchased loans, Hedge accounting improvements); January 1, 2028 (Accounting for internal-use software).

29-04-2026

Forte Biosciences, Inc. (FBRX) filed a DEF 14A proxy statement on April 29, 2026, for its annual meeting of stockholders, proposing the election of three Class III directors: Steven Kornfeld, Scott Brun, M.D., and Paul A. Wagner, Ph.D. (Chairman, President, and CEO), to serve until 2029. The Board comprises eight directors, six of whom are independent under Nasdaq standards, with no reported changes in composition or performance metrics. Stockholder proposal deadlines for the 2027 annual meeting include December 30, 2026, for inclusion in the proxy statement, and advance notices between January 29 and February 28, 2027.

• ·Ages of directors as of April 17, 2026: Steven Kornfeld (58), Scott Brun (58), Paul A. Wagner (55), Barbara K. Finck (79), Stephen K. Doberstein (67), Richard Vincent (63), Shiv Kapoor (51), David Gryska (70).
• ·Company address: 3060 Pegasus Park Drive, Building 6, Dallas, Texas 75247; Tel: (310) 618-6994; Email: investors@fortebiorx.com.
• ·Advance notice for 2027 stockholder proposals (not for proxy inclusion): not earlier than January 29, 2027 at 5:00 p.m. ET and not later than February 28, 2027 at 5:00 p.m. ET.

29-04-2026

Ategrity Specialty Insurance Company Holdings (NYSE: ASIC) reported Q1 2026 net income attributable to stockholders of $25.5 million, up 201.0% YoY from $8.5 million, driven by gross written premiums growth of 23.1% to $142.9 million and underwriting income increase of 86.6% to $13.3 million. The combined ratio improved to 87.4% from 90.9%, with loss ratio at 58.8% (down 1.0 pp) and expense ratio at 28.6% (down 2.5 pp), reflecting efficient scaling. Casualty gross written premiums rose 27.4% while property increased 12.6%, supporting adjusted ROE of 16.4%.

• ·Book value per share at Q1 2026 end: $13.13, up 24.3% from Q1 2025.
• ·Net investment income: $12.0 million in Q1 2026 vs $7.9 million in Q1 2025.
• ·Net realized and unrealized gains on investments: $9.5 million in Q1 2026 vs ($4.6 million) loss in Q1 2025.
• ·Loss ratio: 58.8% in Q1 2026 (down from 59.8%).
• ·Expense ratio components: Policy acquisition costs 17.6% of net earned premiums (down from 18.8%); Operating expenses net of fee income 10.9% (down from 12.3%).

29-04-2026

GBank Financial Holdings Inc. reported Q1 2026 net income of $1.3 million ($0.09 per diluted share), down significantly QoQ from $7.4 million due to $3.2 million after-tax credit card fraud losses, though adjusted net income was $4.7 million ($0.31 per share); net revenue fell 5.2% QoQ to $19.6 million while rising 13.2% YoY. Loan originations jumped to $208.1 million from $126.4 million QoQ, driving total loans over $1.0 billion for the first time, but net interest income declined 9.4% QoQ to $12.2 million, NIM compressed to 3.86%, and efficiency ratio deteriorated to 80.8% amid higher provisions and expenses.

• ·Net loan charge-offs $1.5 million (0.57% annualized) in Q1 2026, up from $0.557 million (0.21%) in Q4 2025
• ·Non-performing assets $44.1 million as of March 31, 2026, up $6.7 million QoQ
• ·Issued $11.0 million subordinated debt in January 2026 (matures 2036); redeemed $6.5 million prior notes
• ·Available borrowing capacity $480.5 million as of March 31, 2026
• ·Book value per share $11.58 as of March 31, 2026, up 0.5% QoQ and 12.8% YoY

29-04-2026

MVB Financial Corp. reported Q1 2026 net income of $5.2 million ($0.41 basic EPS), up from $4.2 million in Q4 2025 and $3.6 million in Q1 2025, driven by 2.6% QoQ loan growth to $2.40 billion, 10.7% reduction in noninterest expenses to $28.1 million, and net interest income of $28.5 million with NIM at 3.71%. However, noninterest income declined to $8.2 million from $10.7 million QoQ due to absence of prior holding gain, nonperforming loans rose to 1.4% of loans, and capital ratios like Tier 1 decreased to 12.6%. Subsequent to quarter-end, a $10.0 million pre-tax gain on a Fintech investment is expected, boosting tangible book value by $0.59 per share.

• ·Launched two new Fintech partners in Q1 2026.
• ·Loan-to-deposit ratio 83.0% at Q1 end vs 82.4% prior quarter.
• ·Pre-tax, pre-provision earnings $8.5M in Q1 2026 vs $7.6M Q4 2025.
• ·Tangible book value per share $25.98, down 0.7% QoQ.
• ·Conference call scheduled for April 29, 2026 at 5:00 PM ET.

29-04-2026

VICI Properties reported Q1 2026 total revenues of $1.0 billion, up 3.5% YoY from $984.2 million, AFFO attributable to common stockholders of $650.9 million, up 5.7% YoY, and net income of $872.4 million, up 60.5% YoY primarily due to a $305.7 million favorable change in CECL allowance. The company announced expansion of its $1.5 billion mezzanine loan for the One Beverly Hills development with Cain and Eldridge Industries, a pending $144.4 million acquisition of Canadian casino assets from Gamehost in connection with PURE, and a $1.16 billion acquisition of seven Golden Entertainment casino properties; it also raised full-year 2026 AFFO guidance to $2,665-$2,695 million. Subsequent events include a new lease for MGM Northfield Park and settlement of forward sale agreements for $242.1 million in proceeds.

• ·Liquidity of $3.1 billion as of March 31, 2026, including $2.4 billion revolving credit facility availability.
• ·Declared quarterly dividend of $0.45 per share, paid April 9, 2026.
• ·Entered forward-starting interest rate swaps totaling $500 million notional during and post quarter.

29-04-2026

29-04-2026

29-04-2026

Elicio Therapeutics, Inc. filed a 10-K/A amendment on April 29, 2026, listing exhibits including multiple securities purchase agreements and notes with GKCC, LLC (dated 2023-2025), security and IP agreements, employment agreements for executives like Preetam Shah and Robert Connelly, equity incentive plans, a lease with RREF II 451D, LLC, an at-market issuance sales agreement with B. Riley Securities and others, and an exclusive patent license with MIT. The exhibits reference prior filings such as 8-Ks from 2023-2026 with no new financial metrics or performance data disclosed. This appears to be an update to material contracts without quantitative changes.

29-04-2026

Vertex Pharmaceuticals Incorporated issued a supplement to its April 2, 2026 proxy statement announcing that board nominee Suketu Upadhyay will not stand for re-election at the 2026 Annual Meeting due to scheduling conflicts from his new role as forthcoming CFO of Incyte Corporation. The Board confirmed no disagreements with Mr. Upadhyay on company operations, policies, or practices, and plans to reduce its size to ten members. Previously submitted proxies remain valid except for votes on Mr. Upadhyay.

• ·Withdrawal informed to Board on April 28, 2026.
• ·2026 Annual Meeting scheduled for May 13, 2026 at 9:00 a.m. Eastern Time.
• ·Original proxy statement filed April 2, 2026.

29-04-2026

Niagen Bioscience, Inc. (NAGE) has filed DEFA14A additional proxy materials notifying shareholders of the availability of proxy statements and the 2025 Annual Report for the Annual Shareholder Meeting on June 24, 2026. Shareholders will vote on electing eight director nominees (Frank Jaksch, Jr., Robert Fried, Steven Rubin, Wendy Yu, Gary Ng, Kristin Patrick, Ann Cohen, and Hamed Shahbazi), ratifying Crowe LLP as independent auditors for the fiscal year ending December 31, 2026, and a non-binding advisory vote on named executive officer compensation, with the Board recommending a FOR vote on all proposals. No financial performance data or changes are disclosed in this notice.

• ·Annual Meeting: June 24, 2026 at 3:00 pm PT, 10900 Wilshire Blvd. Suite 600, Los Angeles, CA 90024
• ·Proxy materials request deadline: June 14, 2026
• ·Electronic voting deadline: 11:59 pm ET on June 23, 2026
• ·Online access: www.investorvote.com/NAGE